Articles · Sleep
Melatonin and Sleep in Perimenopause
What melatonin does, where the evidence holds up, and what it will not fix.
Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.
Melatonin is the most widely purchased sleep supplement in the world. In the US it is now among the top five most commonly used supplements across all adult age groups.[1] For perimenopausal women dealing with sleep disruption, it is often one of the first things tried.
Knowing what melatonin actually does, and what it does not do, matters before you decide whether it belongs in your routine.
What Melatonin Is
Melatonin is a hormone the pineal gland produces in response to darkness. As light fades in the evening, the suprachiasmatic nucleus (the brain’s master clock) signals the pineal gland to start releasing it. Melatonin rises through the evening, peaks between 2 and 4 AM, and falls before dawn as cortisol begins its morning rise.
Melatonin does not cause sleep directly. It is a darkness signal: a message that night has arrived and the body’s night processes should begin. That distinction explains both its real uses and its limits.
How Melatonin Changes in Perimenopause
Melatonin production declines with age, starting in the mid-40s and continuing into older age.[2] The decline is gradual, not sudden. By the late perimenopausal years, melatonin secretion is lower than it was in a woman’s 30s.
Estrogen plays a role too. It affects the activity of the enzyme (AANAT) involved in making melatonin, and some research suggests declining estrogen contributes to a lower melatonin peak on top of the age-related decline.[3] Postmenopausal women tend to have lower nighttime melatonin peaks than younger premenopausal women, after adjusting for age.
The practical effect: the darkness signal that should start sleep may be weaker and shorter, making it harder to fall asleep and to hold onto deep sleep through the night.
What the Evidence Shows
Sleep onset
The strongest evidence for melatonin is reducing sleep latency, the time it takes to fall asleep. A meta-analysis by Ferracioli-Oda et al. (2013) of 19 randomized controlled trials found that melatonin reduced sleep onset latency by an average of seven minutes compared with placebo.[4] That is statistically significant and real, but modest. For someone lying awake 45 minutes before sleep, seven fewer minutes is a small improvement.
Effects are larger in circadian rhythm disorders (jet lag, shift work disorder, delayed sleep phase syndrome), where melatonin’s role as a timing signal is directly relevant. For general insomnia, the evidence is weaker.
Perimenopausal sleep specifically
The evidence in perimenopausal women is limited. A randomized trial by Toffol et al. (2014) found that melatonin (3 mg nightly) improved sleep quality on a composite sleep scale, with greater effects in those with more severe baseline disruption.[5] A smaller study by Bellipanni et al. (2001) found improvements in sleep and mood in postmenopausal women taking melatonin, though the study design had limitations.[6]
For sleep broken by hot flashes waking women during the night, melatonin does not address the cause. Hot flashes and night sweats trigger arousals regardless of melatonin level; the problem is not difficulty falling asleep but sleep being interrupted by a physical event. Melatonin is more relevant to falling asleep in the first place than to the waking caused by night sweats.
Dose and Timing
Commercial products and clinical evidence diverge here.
Most over-the-counter melatonin products in the US contain doses between 5 mg and 10 mg per tablet. Some contain as much as 20 mg. The clinical evidence for sleep onset uses doses between 0.5 mg and 3 mg. Higher doses do not produce proportionally larger effects. They extend the time melatonin stays elevated, prolong the drop in core body temperature, and raise the chance of next-morning grogginess.[7]
Research on timing is consistent: melatonin taken 30 to 60 minutes before the intended sleep time is most effective for reducing sleep onset latency. Taking it earlier risks shifting the circadian rhythm rather than helping that night’s sleep.
Dose guidance based on evidence:
- Start with 0.5 to 1 mg, 30 to 60 minutes before bed
- 3 mg is the upper end of doses with evidence for sleep onset effects in perimenopausal women
- Doses above 3 mg are not supported by evidence for better outcomes and increase side-effect risk
In the UK, melatonin is a prescription-only medicine and cannot legally be sold over the counter, though imported products are widely available online. Circadin (2 mg prolonged-release) is available on NHS prescription for adults aged 55 and over with insomnia. Doctors can prescribe off-label for younger patients where clinically appropriate.
In the US, melatonin is sold over the counter as a dietary supplement without dose regulation.
Light Management as a First Step
Because melatonin is a darkness signal, the most targeted way to support natural production is not a supplement but light management.
Bright light in the morning (ideally outdoor light within an hour of waking, or a 10,000-lux light therapy lamp for 20 to 30 minutes) anchors the body clock and helps melatonin onset happen at the right time in the evening.[8]
Less blue light in the evening (from screens, LED overhead lighting) delays melatonin onset. Screen filter settings reduce but do not eliminate this. Dimming overall light and cutting screen use in the 90 minutes before bed produces a more consistent benefit.[9]
These work with the same biological system that melatonin supplements try to influence. For women whose sleep problem is mainly about falling asleep rather than hot flash waking, fixing light exposure is the better first step.
When Melatonin Helps Most
Melatonin at low doses (0.5 to 3 mg) is a reasonable option for:
- Difficulty falling asleep at the start of the night, particularly if sleep onset feels later than it should
- Jet lag recovery (well-evidenced, with timing that depends on direction of travel)
- Shift workers rotating between day and night shifts
It is less likely to help with:
- Sleep broken by hot flashes once it has started
- Being unable to get back to sleep after waking in the early hours
- Non-restorative sleep that is not fragmented
For hot-flash-disrupted sleep, treating the hot flashes is the effective path. HRT is the most evidence-based option; non-hormonal alternatives exist for those who cannot use it.
Safety
Melatonin at standard doses (0.5 to 5 mg) has a good short-term safety profile. The main documented side effects at higher doses are next-morning sedation, vivid or disturbing dreams, and headache. It is not habit-forming and does not suppress the body’s own melatonin production with regular use at standard doses.[10]
Long-term safety data are limited. Most guidelines recommend using the lowest effective dose for the shortest necessary period rather than indefinite nightly use.
Melatonin may interact with anticoagulants (warfarin), immunosuppressants, and diabetes medications. If you take any regular prescription medication, mention melatonin use to your prescriber.
Frequently Asked Questions
Does melatonin help with menopause insomnia?
It can help with falling asleep, but not with sleep broken by hot flashes. The evidence supports low-dose melatonin (0.5 to 3 mg) modestly reducing the time it takes to fall asleep,[4] and a perimenopause-specific trial found improved overall sleep quality as well.[5] It doesn’t address night sweats waking you up once you’re already asleep. That’s a separate problem best solved by treating the hot flashes themselves.
References
[1] National Institutes of Health. (2022). National Health Interview Survey: Use of complementary health approaches in the US. NCCIH. https://www.nccih.nih.gov/research/statistics
[2] Touitou, Y. (2001). Human aging and melatonin: Clinical relevance. Experimental Gerontology, 36(7), 1083–1100. https://doi.org/10.1016/s0531-5565(01)00120-6
[3] Okatani, Y., Morioka, N., Wakatsuki, A. (2000). Changes in nocturnal melatonin secretion in perimenopausal women: Correlation with endogenous estrogen concentrations. Journal of Pineal Research, 28(2), 111–118. https://doi.org/10.1034/j.1600-079x.2000.280207.x
[4] Ferracioli-Oda, E., Qawasmi, A., Bloch, M. H. (2013). Meta-analysis: Melatonin for the treatment of primary sleep disorders. PLOS ONE, 8(5), e63773. https://doi.org/10.1371/journal.pone.0063773
[5] Toffol, E., Kalleinen, N., Urrila, A. S., Himanen, S. L., Porkka-Heiskanen, T., Polo-Kantola, P. (2014). The relationship between mood and sleep in different female reproductive states. BMC Psychiatry, 14, 177. https://doi.org/10.1186/1471-244X-14-177
[6] Bellipanni, G., Bianchi, P., Pierpaoli, W., Bulian, D., Ilyia, E. (2001). Effects of melatonin in perimenopausal and menopausal women: A randomized and placebo controlled study. Experimental Gerontology, 36(2), 297–310. https://doi.org/10.1016/s0531-5565(00)00217-5
[7] Zhdanova, I. V., Wurtman, R. J., Lynch, H. J., et al. (1995). Sleep-inducing effects of low doses of melatonin ingested in the evening. Clinical Pharmacology and Therapeutics, 57(5), 552–558. https://doi.org/10.1016/0009-9236(95)90040-3
[8] Duffy, J. F., Czeisler, C. A. (2009). Effect of light on human circadian physiology. Sleep Medicine Clinics, 4(2), 165–177. https://doi.org/10.1016/j.jsmc.2009.01.004
[9] Chang, A. M., Aeschbach, D., Duffy, J. F., Czeisler, C. A. (2015). Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. Proceedings of the National Academy of Sciences, 112(4), 1232–1237. https://doi.org/10.1073/pnas.1418490112
[10] Besag, F. M. C., Vasey, M. J., Lao, K. S. J., Wong, I. C. K. (2019). Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: A systematic review. CNS Drugs, 33(12), 1167–1186. https://doi.org/10.1007/s40263-019-00680-w
Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.